The bill specifically amends Chapter 111 of the General Laws by replacing the existing regulations pertaining to notifications required from healthcare providers connected to admissions or services that are not emergency-related. Such changes are expected to improve patient experiences by reducing ambiguities surrounding financial responsibilities and making out-of-pocket costs clearer from the onset of care. Importantly, if a patient is involved in a series of ongoing treatments, the initial disclosure is intended to suffice, limiting the need for repetitive notifications for further services, which can reduce admin burdens on providers.
Summary
S762, also known as the Act Relative to Streamlining Notice and Disclosure, is a proposed change to the laws governing health care provider and health insurance carrier disclosures in Massachusetts. The bill aims to enhance transparency in the costs associated with healthcare services by requiring health care providers to disclose their participation status in patients' health benefit plans and to provide good faith estimates of expected costs for scheduled admissions, procedures, or services. This initiative aims to empower patients by ensuring they have clear information about the financial aspects of their healthcare prior to receiving service, which could lead to more informed decision-making regarding their healthcare options.
Contention
One of the notable points of contention connected with S762 involves the compliance requirements set forth for healthcare providers and insurance carriers, particularly regarding penalties for non-compliance which can amount to $5,000 for each violation. Stakeholders are concerned about the practicability of these disclosures and their potential impacts on both patient care and administrative practices within health facilities. While the goal of the bill is to increase transparency and protect patients, there are voices advocating for a careful examination of the implications these requirements may have on healthcare provider operations and their communication abilities with patients.
Allows the healthcare facility to conduct human-subject research on patients subject to 21 C.F.R. Pt 50 and/or 45 C.F.R. Pt 46 (relating to the informed consent of human subjects).
Allows the healthcare facility to conduct human-subject research on patients subject to 21 C.F.R. Pt 50 and/or 45 C.F.R. Pt 46 (relating to the informed consent of human subjects).